Columbia Research Enhanced International Equity ETF (REFA)
NYSEARCA: REFA · Real-Time Price · USD
21.37
-0.67 (-3.03%)
Mar 5, 2026, 4:00 PM EST - Market closed
-3.03% (1D)
| Assets | $5.40M |
| Expense Ratio | 0.32% |
| PE Ratio | 16.87 |
| Shares Out | 250,050 |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.03% |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Ratio | 0.51% |
| 1-Year Return | n/a |
| Volume | 1,016 |
| Open | 21.60 |
| Previous Close | 22.04 |
| Day's Range | 21.27 - 22.04 |
| 52-Week Low | 20.19 |
| 52-Week High | 22.89 |
| Beta | n/a |
| Holdings | 209 |
| Inception Date | Dec 11, 2025 |
About REFA
Fund Home PageThe Columbia Research Enhanced International Equity ETF (REFA) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a market-cap-weighted index of large- and mid-cap companies in developed international markets outside North America. Stock selection is based on proprietary ratings. REFA was launched on Dec 11, 2025 and is issued by Columbia Threadneedle.
Asset Class Equity
Category Foreign Large Blend
Region Global
Stock Exchange NYSEARCA
Ticker Symbol REFA
ETF Provider Columbia Threadneedle
Index Tracked Beta Advantage Research Enhanced International Equity Index
Top 10 Holdings
27.92% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 4.98% |
| Roche Holding AG | ROG | 3.69% |
| Novartis AG | NOVN | 3.57% |
| BHP Group Limited | BHP | 3.46% |
| Hitachi, Ltd. | 6501 | 2.26% |
| Sony Group Corporation | 6758 | 2.17% |
| AstraZeneca PLC | AZN | 2.15% |
| Shell plc | SHEL | 2.00% |
| Mitsubishi Corporation | 8058 | 1.87% |
| Siemens Energy AG | ENR | 1.77% |
News
Columbia Threadneedle Investments Launches Six New ETFs Across Equity and Fixed Income
BOSTON--(BUSINESS WIRE)--Columbia Threadneedle Investments today announced the launch of six new exchange-traded funds (ETFs), further expanding its differentiated range of actively managed and Resear...
2 months ago - Business Wire